ENALAPRIL (MK421) ACTIVATION IN MAN - IMPORTANCE OF LIVER STATUS

被引：28

作者：

LARMOUR, I

JACKSON, B

CUBELA, R

JOHNSTON, CI

机构：

[1] PRINCE HENRYS HOSP, MONASH DEPT MED, MELBOURNE, VIC 3004, AUSTRALIA

[2] PRINCE HENRYS HOSP, PHARM SERV, MELBOURNE, VIC 3004, AUSTRALIA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 19卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1985.tb02699.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：701 / 704

页数：4

共 8 条

[1] ENALAPRIL MALEATE AND A LYSINE ANALOG (MK-521) IN NORMAL VOLUNTEERS - RELATIONSHIP BETWEEN PLASMA DRUG LEVELS AND THE RENIN-ANGIOTENSIN SYSTEM [J].

BIOLLAZ, J ;

SCHELLING, JL ;

COMBES, BJD ;

BRUNNER, DB ;

DESPONDS, G ;

BRUNNER, HR ;

ULM, EH ;

HICHENS, M ;

GOMEZ, HJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :363-368

[2] ENALAPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN CHRONIC HEART-FAILURE - ACUTE AND CHRONIC HEMODYNAMIC EVALUATIONS [J].

DICARLO, L ;

CHATTERJEE, K ;

PARMLEY, WW ;

SWEDBERG, K ;

ATHERTON, B ;

CURRAN, D ;

CUCCI, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 2 (05) :865-871

[3] CAPTOPRIL - A PRELIMINARY REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY [J].

HEEL, RC ;

BROGDEN, RN ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1980, 20 (06) :409-452

[4]

HITCHENS M, 1981, LIGAND Q, V4, P43

[5]

JACKSON B, 1982, CLIN EXP PHARMACOL P, P99

[6]

JOHNSTON CI, 1982, CLIN EXP PHARMACOL P, P135

[7]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

[8] CAPTOPRIL - AN UPDATE REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN CONGESTIVE HEART-FAILURE [J].

ROMANKIEWICZ, JA ;

BROGDEN, RN ;

HEEL, RC ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1983, 25 (01) :6-40

← 1 →